Indivior Pharmaceuticals, Inc. (INDV) Net margin 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) net profit margin by fiscal year — reported net income divided by reported revenue.
16.9%FY2025 · since FY2022: -4.7% → 16.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 16.9% | +16.4 pp |
| FY2024 | 0.6% | +12.1 pp |
| FY2023 | -11.5% | -6.9 pp |
| FY2022 | -4.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Gross profitINDV Gross marginINDV Operating incomeINDV Operating marginINDV Operating cash flowINDV Free cash flowINDV Capital expendituresINDV Return on equityINDV Stock buybacksINDV Dividends paidINDV Total assetsINDV Total liabilitiesINDV Shareholders’ equityINDV overview →